These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 102333)

  • 1. Inhibition of the growth of murine tumour cells in vitro by serum from non-immune syngeneic and allogeneic mice.
    Ablett G; Bishop C; Sheridan JW; Donald KJ
    Br J Exp Pathol; 1978 Oct; 59(5):522-9. PubMed ID: 102333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-immunological cell death of intravenously injected murine tumour cells.
    Bishop CJ; Donald KJ
    Br J Exp Pathol; 1979 Feb; 60(1):29-37. PubMed ID: 111696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth enhancement and serum replacement in cloning of murine mastocytoma and granulocyte/macrophage precursor cells: two distinct activities present in hemolysates.
    Rothmann J; Hertogs CF; Pluznik DH
    Exp Hematol; 1979 Aug; 7(7):352-60. PubMed ID: 114402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.
    Doherty PC; Zinkernagel RM
    Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
    Kamo I; Patel C; Kateley J; Friedman H
    J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells.
    Bishop CJ; Sheridan JW; Donald KJ
    Br J Exp Pathol; 1981 Feb; 62(1):22-6. PubMed ID: 6784742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of growth of mouse mastocytoma cells.
    Davis J; Ralph RK
    Cancer Res; 1975 Jun; 35(6):1495-504. PubMed ID: 165878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity is closely associated with a growth-inhibitory serum protein with protease-like activity.
    Gundersen S; Funderud S; Bloom BR; Godal T
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):137-45. PubMed ID: 6410683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation.
    Sakano T; Wilbur SM; Bonavida B
    Cancer Res; 1985 Apr; 45(4):1573-8. PubMed ID: 3884142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
    Paulsen JE; Elgjo K
    In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo.
    Glasgow LA; Crane JL; Kern ER; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1881-8. PubMed ID: 282006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.
    Lee G; Namen AE; Gillis S; Ellingsworth LR; Kincade PW
    J Immunol; 1989 Jun; 142(11):3875-83. PubMed ID: 2785567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide.
    Aune TM; Pogue SL
    J Clin Invest; 1989 Sep; 84(3):863-75. PubMed ID: 2503544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.